Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cabaletta Bio, Inc. - Common Stock (NQ:CABA)

2.765 -0.175 (-5.95%)
Streaming Delayed Price Updated: 2:11 PM EDT, Mar 23, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cabaletta Bio, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
Cabaletta Bio to Present New and Updated Clinical Data on CABA-201 in Oral and Poster Presentations at ACR Convergence 2024
From Cabaletta Bio
Via GlobeNewswire
News headline image
Cabaletta Bio to Participate in Upcoming Investor Conferences in September
From Cabaletta Bio
Via GlobeNewswire
News headline image
CABA Stock Earnings: Cabaletta Bio Misses EPS for Q2 2024 ↗
CABA stock results show that Cabaletta Bio missed analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
News headline image
Cabaletta Bio Reports Second Quarter 2024 Financial Results and Provides Business Update
From Cabaletta Bio
Via GlobeNewswire
News headline image
Recap: Cabaletta Bio Q4 Earnings ↗
 
Via Benzinga
Cabaletta Bio Inc. (NASDAQ: CABA) is a Stock Spotlight on 12/8
Via Investor Brand Network
News headline image
Cell Therapy Mostly Used For Blood Cancer Shows Efficacy In Autoimmune Diseases As Well, But There Are Challenges ↗
CAR-T therapy, originally used for blood cancers, shows promising results in treating lupus, as evidenced by Janina Paech's remarkable remission. This breakthrough offers new hope for autoimmune... 
Via Benzinga
News headline image
Cabaletta Bio to Participate in the Stifel 2024 Virtual Cell Therapy Forum
From Cabaletta Bio
Via GlobeNewswire
News headline image
Why Kaival Brands Innovations Shares Are Trading Lower By 47%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
 
Via Benzinga
News headline image
Asana, Clover Health Investments, Hertz Global And Other Big Stocks Moving Higher On Friday ↗
 
Via Benzinga
News headline image
Why Quantum Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
 
Via Benzinga
News headline image
Why AMMO Shares Are Trading Lower By Over 19%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
 
Via Benzinga
News headline image
Cabaletta Bio Reports Positive Initial Clinical Data from Phase 1/2 RESET-Myositis™ and RESET-SLE™ Trials of CABA-201
From Cabaletta Bio
Via GlobeNewswire
News headline image
Cabaletta Bio to Participate in the Jefferies Global Healthcare Conference
From Cabaletta Bio
Via GlobeNewswire
News headline image
CABA Stock Earnings: Cabaletta Bio Misses EPS for Q1 2024 ↗
CABA stock results show that Cabaletta Bio missed analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
News headline image
NEXTracker Posts Upbeat Earnings, Joins monday.com, Nu Holdings And Other Big Stocks Moving Higher On Wednesday ↗
 
Via Benzinga
News headline image
Why Bolt Biotherapeutics Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
 
Via Benzinga
News headline image
Cabaletta Bio Reports First Quarter 2024 Financial Results and Provides Business Update
From Cabaletta Bio
Via GlobeNewswire
News headline image
Cabaletta Bio to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ
From Cabaletta Bio
Via GlobeNewswire
News headline image
CABA Stock Earnings: Cabaletta Bio Misses EPS for Q4 2023 ↗
CABA stock results show that Cabaletta Bio missed analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
News headline image
Cabaletta Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
From Cabaletta Bio
Via GlobeNewswire
News headline image
Cabaletta Bio Announces FDA Granted Orphan Drug Designation to CABA-201 for Treatment of Systemic Sclerosis
From Cabaletta Bio
Via GlobeNewswire
News headline image
Cramer: This REIT Is 'A Little Too Dicey'; As For Marathon Digital, 'Own The Pure' ↗
On CNBC’s "Mad Money Lightning Round," Jim Cramer recommended holding onto Regions Financial Corporation (NYSE: RF). 
Via Benzinga
News headline image
Cabaletta Bio to Participate in Upcoming Investor Conferences in March
From Cabaletta Bio
Via GlobeNewswire
News headline image
Cabaletta Bio Announces FDA Granted Orphan Drug Designation to CABA-201 for Treatment of Myositis
From Cabaletta Bio
Via GlobeNewswire
News headline image
Cabaletta Bio to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
From Cabaletta Bio
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
 
Via Benzinga
News headline image
Cabaletta Bio Receives Additional FDA Fast Track Designations for CABA-201 in Dermatomyositis and Systemic Sclerosis
From Cabaletta Bio
Via GlobeNewswire
News headline image
Cabaletta Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference
From Cabaletta Bio
Via GlobeNewswire
News headline image
Verint Reports Strong Earnings, Joins Semtech, Alphabet And Other Big Stocks Moving Higher On Thursday ↗
U.S. stocks traded mostly higher, with the Nasdaq Composite gaining more than 100 points on Thursday. 
Via Benzinga
Topics Stocks
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.